服务热线
400-0689-033
| 品牌 | 货号 | 产品名称 | 描述 | CAS | 规格 | 单价（￥） | 货期 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| 麦克林 | R854248-100mg | (R)-3,3'-双(4-甲氧基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯 | ≥98%,99%e.e. | 1011465-27-2 | 100mg |
3150.00
3150.00 |
咨询 |
|
| 麦克林 | R854241-100mg | (11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥95%,99%e.e. | 1011465-29-4 | 100mg |
5062.00
5062.00 |
咨询 |
|
| 麦克林 | A801598-100mg | Arg-Phe acetate salt | 98% | 102029-92-5 | 100mg |
548.00
548.00 |
咨询 |
|
| 麦克林 | R857210-100mg | (11BR)-N-甲基-N-[(R)-1-苯基乙基]-联萘并[2,1-D:1',2'-F][1,3,2]二氧膦杂-4-胺 | 98%,ee99% | 1021439-57-5 | 100mg |
4500.00
4500.00 |
咨询 |
|
| 麦克林 | S854033-100mg | (S)-3,3’-二苯基-1,1’-联萘酚 | ≥98%,99%e.e. | 102490-05-1 | 100mg |
1687.00
1687.00 |
咨询 |
|
| 麦克林 | S854240-100mg | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 1028416-47-8 | 100mg |
5130.00
5130.00 |
咨询 |
|
| 麦克林 | S854079-100mg | (S)-5,5',6,6',7,7',8,8'-八氢-3,3'-二-9-菲基-1,1'-联萘酚 | ≥95%,99%e.e. | 1028416-48-9 | 100mg |
3411.00
3411.00 |
咨询 |
|
| 麦克林 | S854067-100mg | (S)-4,4',6,6'-四三氟甲基-[1,1'-联苯]-2,2'-二胺 | ≥98%,99%e.e. | 1037800-48-8 | 100mg |
3780.00
3780.00 |
咨询 |
|
| 麦克林 | R854066-100mg | (R)-4,4',6,6'-四三氟甲基-[1,1'-联苯]-2,2'-二胺 | ≥98%,99%e.e. | 1037800-51-3 | 100mg |
3780.00
3780.00 |
咨询 |
|
| 麦克林 | R854070-100mg | (R)-3,3’-双(三苯基硅基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚 | ≥95%,99%e.e. | 1041186-22-4 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | S854041-100mg | (S)-3,3'-双(2,4,6-三甲基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1041858-16-5 | 100mg |
3375.00
3375.00 |
咨询 |
|
| 麦克林 | R854161-100mg | (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁-2-基]硫脲 | ≥98%,99%e.e. | 1048692-61-0 | 100mg |
2936.00
2936.00 |
咨询 |
|
| 麦克林 | S854315-100mg | (5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Tetrafluoroborate | ≥98%,99%e.e. | 1061311-82-7 | 100mg |
1550.00
1550.00 |
咨询 |
|
| 麦克林 | R854233-100mg | (R)-3,3'-双(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1065214-95-0 | 100mg |
3143.00
3143.00 |
咨询 |
|
| 麦克林 | D855487-100mg | 1,3-二乙烯苯 | 95% | 108-57-6 | 100mg |
890.00
890.00 |
咨询 |
|
| 麦克林 | X820547-100mg | XTT钠盐 | 90% | 111072-31-2 | 100mg |
1360.00
1360.00 |
1周 |
|
| 麦克林 | S854018-100mg | (S)-3,3'-双(三苯甲硅烷基)-1,1'-联萘酚 | ≥98%,99%e.e. | 111795-33-6 | 100mg |
2153.00
2153.00 |
咨询 |
|
| 麦克林 | S854091-100mg | (S)-3,3'-双(4-甲氧基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚 | ≥98%,99%e.e. | 1121764-44-0 | 100mg |
2205.00
2205.00 |
咨询 |
|
| 麦克林 | S854076-100mg | (S)-3,3'-双(2-萘基)-5,5',6,6',7,7',8,8'-八氢联萘酚 | ≥95%,99%e.e. | 1121764-48-4 | 100mg |
2349.00
2349.00 |
咨询 |
|
| 麦克林 | S854094-100mg | (S)-3,3'-双(2,4,6-三甲基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚 | ≥98%,99%e.e. | 1121764-50-8 | 100mg |
3465.00
3465.00 |
咨询 |
|
| 麦克林 | E861182-100mg | 盐酸恩诺沙星 | 分析标准品 | 112732-17-9 | 100mg |
520.00
520.00 |
咨询 |
|
| 麦克林 | R854014-100mg | (βR)-β-Cyclopropyl-3-hydroxybenzenepropanoic Acid Methyl Ester | ≥95%,≥99%e.e. | 1142223-06-0 | 100mg |
2700.00
2700.00 |
咨询 |
|
| 麦克林 | S854230-100mg | (S)-3,3'-双(三苯基硅基)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯 | ≥98%,99%e.e. | 1157989-25-7 | 100mg |
5670.00
5670.00 |
咨询 |
|
| 麦克林 | S854198-100mg | (S)-3,3'-双(3,5-二甲基苯基)-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1170736-59-0 | 100mg |
2542.00
2542.00 |
咨询 |
|
| 麦克林 | B854470-100mg | 2,5-双(2-乙基己基)-3,6-二(2-噻吩基)-2,5-二氢吡咯并[3,4-c]吡咯-1,4-二酮 | >98.0%(HPLC) | 1185885-86-2 | 100mg |
980.00
980.00 |
咨询 |
|
| 麦克林 | R854226-100mg | (11bR)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥95%,99%e.e. | 1191451-24-7 | 100mg |
3116.00
3116.00 |
咨询 |
|
| 麦克林 | S854051-100mg | (S)-3,3'-双(4-甲氧基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1199631-29-2 | 100mg |
2216.00
2216.00 |
咨询 |
|
| 麦克林 | S854056-100mg | (S)-3,3'-双(4-氯苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1204609-08-4 | 100mg |
2218.00
2218.00 |
咨询 |
|
| 麦克林 | R854077-100mg | (R)-3,3'-双(1-萘基)-5,5',6,6',7,7',8,8'-八氢联萘酚 | ≥98%,99%e.e. | 1205537-79-6 | 100mg |
2349.00
2349.00 |
咨询 |
|
| 麦克林 | R854083-100mg | (R)-3,3'-双[4-叔丁基苯基]-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚 | ≥98%,99%e.e. | 1205537-80-9 | 100mg |
2700.00
2700.00 |
咨询 |
|
| 麦克林 | S854205-100mg | (S)-3,3'-双(4-叔丁基苯基)-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1217901-32-0 | 100mg |
3433.00
3433.00 |
咨询 |
|
| 麦克林 | R854252-100mg | (R)-3,3'-双(1-芘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯 | ≥98%,99%e.e. | 1225195-02-7 | 100mg |
4770.00
4770.00 |
咨询 |
|
| 麦克林 | D854469-100mg | 2,6-二溴-4,8-双(2-乙基己氧基)苯并[1,2-b:4,5-b']联噻吩 | >97.0%(HPLC) | 1226782-13-3 | 100mg |
1590.00
1590.00 |
咨询 |
|
| 麦克林 | S854089-100mg | (S)-5,5',6,6',7,7',8,8'-八氢-3,3'-双[4-(三氟甲基)苯基]-1,1'-联萘酚 | ≥98%,99%e.e. | 1228600-98-3 | 100mg |
2205.00
2205.00 |
咨询 |
|
| 麦克林 | S854074-100mg | (S)-3,3'-双(3,5-双(三氟甲基)苯基)-5,5’,6,6’,7,7’,8,8’-八氢联萘酚 | ≥98%,99%e.e. | 1228600-99-4 | 100mg |
2211.00
2211.00 |
咨询 |
|
| 麦克林 | R854236-100mg | (R)-3,3'-双(1-萘基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚膦酸酯 | ≥95%,99%e.e. | 1242066-20-1 | 100mg |
3197.00
3197.00 |
咨询 |
|
| 麦克林 | R854129-100mg | (4R,4'R)-2,2'-环亚戊基双[4,5-二氢-4-苯基噁唑 | ≥95%,99%e.e. | 1246401-49-9 | 100mg |
3600.00
3600.00 |
咨询 |
|
| 麦克林 | R853872-100mg | (11bR,11'bR)- 4,4'-[(1S,2S)-1,2-二苯基-1,2-乙二基]-双[4,5-二氢-H-联萘并[2,1-c:1',2'-e]氮杂卓 | ≥95%,≥99%e.e. | 1256952-84-7 | 100mg |
2535.00
2535.00 |
咨询 |
|
| 麦克林 | S854264-100mg | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1258276-28-6 | 100mg |
7391.00
7391.00 |
咨询 |
|
| 麦克林 | S854098-100mg | (S)-2,2',3,3'-Tetrahydro-6,6'-diphenyl-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1258326-98-5 | 100mg |
4304.00
4304.00 |
咨询 |
|
| 麦克林 | S854108-100mg | (S)-6,6'-Bis(4-chlorophenyl)-2,2',3,3'-tetrahydro-1,1'spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1258326-99-6 | 100mg |
4081.00
4081.00 |
咨询 |
|
| 麦克林 | S854107-100mg | (S)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1258327-00-2 | 100mg |
6045.00
6045.00 |
咨询 |
|
| 麦克林 | S854100-100mg | (S)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1258327-01-3 | 100mg |
4425.00
4425.00 |
咨询 |
|
| 麦克林 | S854103-100mg | (S)-2,2',3,3'-Tetrahydro-6,6'-di(1-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1258327-02-4 | 100mg |
4569.00
4569.00 |
咨询 |
|
| 麦克林 | S854254-100mg | (S)-螺环二酚膦酸酯 | ≥98%,99%e.e. | 1258327-03-5 | 100mg |
1518.00
1518.00 |
咨询 |
|
| 麦克林 | S854256-100mg | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1258327-04-6 | 100mg |
5316.00
5316.00 |
咨询 |
|
| 麦克林 | S854271-100mg | (11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥95%,99%e.e. | 1258327-05-7 | 100mg |
5438.00
5438.00 |
咨询 |
|
| 麦克林 | S854258-100mg | (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1258327-07-9 | 100mg |
5640.00
5640.00 |
咨询 |
|
| 麦克林 | S854261-100mg | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1258327-08-0 | 100mg |
5863.00
5863.00 |
咨询 |
|
| 麦克林 | S854224-100mg | (S)-3,3'-双(4-三氟甲基苯基)-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1264573-23-0 | 100mg |
2544.00
2544.00 |
咨询 |
|
| 麦克林 | R853974-100mg | (αR,α'R)-α,α'-Bis(tert-butyl)-[2,2'-bipyridine]-6,6'-dimethanol | ≥98%,≥99% e.e. | 127049-50-7 | 100mg |
4387.00
4387.00 |
咨询 |
|
| 麦克林 | S853977-100mg | (S)-1-(6-Bromopyridin-2-yl)-2,2-dimethylpropan-1-ol | ≥98%,≥99% e.e. | 127049-52-9 | 100mg |
1923.00
1923.00 |
咨询 |
|
| 麦克林 | R853976-100mg | (R)-1-(6-Bromopyridin-2-yl)-2,2-dimethylpropan-1-ol | ≥98%,≥99% e.e. | 127912-58-7 | 100mg |
1923.00
1923.00 |
咨询 |
|
| 麦克林 | R854099-100mg | (R)-6,6'-Bis[3,5-bis(trifluoromethyl)phenyl]-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1286189-16-9 | 100mg |
4425.00
4425.00 |
咨询 |
|
| 麦克林 | S854087-100mg | (S)-5,5',6,6',7,7',8,8'-八氢-3,3'-二-1-芘基-1,1'-联萘酚 | ≥95%,99%e.e. | 1286189-19-2 | 100mg |
3262.00
3262.00 |
咨询 |
|
| 麦克林 | R854102-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-di(1-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1292849-40-1 | 100mg |
4569.00
4569.00 |
咨询 |
|
| 麦克林 | R854104-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-di(2-naphthalenyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1297613-70-7 | 100mg |
4448.00
4448.00 |
咨询 |
|
| 麦克林 | R854106-100mg | (R)-6,6'-Bis([1,1'-biphenyl]-4-yl)-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | ≥95%,99%e.e. | 1297613-71-8 | 100mg |
6045.00
6045.00 |
咨询 |
|
| 麦克林 | R854255-100mg | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1297613-72-9 | 100mg |
5316.00
5316.00 |
咨询 |
|
| 麦克林 | R854260-100mg | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1297613-73-0 | 100mg |
5863.00
5863.00 |
咨询 |
|
| 麦克林 | R854262-100mg | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1297613-74-1 | 100mg |
5856.00
5856.00 |
咨询 |
|
| 麦克林 | R854259-100mg | (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1297613-75-2 | 100mg |
5643.00
5643.00 |
咨询 |
|
| 麦克林 | R854257-100mg | (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1297613-76-3 | 100mg |
5640.00
5640.00 |
咨询 |
|
| 麦克林 | S853975-100mg | (αS,α'S)-α,α'-Bis(tert-butyl)-[2,2'-bipyridine]-6,6'-dimethanol | ≥98%,≥99% e.e. | 131726-65-3 | 100mg |
4387.00
4387.00 |
咨询 |
|
| 麦克林 | D854463-100mg | 2,6-二溴-4,8-双[(2-丁基正辛基)氧]苯并[1,2-b:4,5-b']二噻吩 | >94.0%(HPLC) | 1336893-15-2 | 100mg |
2190.00
2190.00 |
咨询 |
|
| 麦克林 | S854313-100mg | (S)-2-[Diphenyl[[trisisopropylsilyl]oxy]methyl]pyrrolidine | ≥98%,99%e.e. | 1339961-44-2 | 100mg |
1687.00
1687.00 |
咨询 |
|
| 麦克林 | R854109-100mg | (R)-6,6'-Di-9-anthracenyl-2,2',3,3'-tetrahydro-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1345628-15-0 | 100mg |
6066.00
6066.00 |
咨询 |
|
| 麦克林 | N857170-100mg | (R)-N,N',N,N'-四甲基联萘胺 | 98%,ee99% | 135029-77-5 | 100mg |
3500.00
3500.00 |
咨询 |
|
| 麦克林 | R854114-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-bis(4-nitrophenyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1352810-33-3 | 100mg |
4522.00
4522.00 |
咨询 |
|
| 麦克林 | R854112-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-bis([1,1':3',1''-terphenyl]-5'-yl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1352810-34-4 | 100mg |
3712.00
3712.00 |
咨询 |
|
| 麦克林 | R854253-100mg | (R)-螺环二酚膦酸酯 | ≥98%,99%e.e. | 1352810-35-5 | 100mg |
1518.00
1518.00 |
咨询 |
|
| 麦克林 | R854272-100mg | (11aR)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥95%,99%e.e. | 1352810-37-7 | 100mg |
5411.00
5411.00 |
咨询 |
|
| 麦克林 | R854054-100mg | (R)-3,3'-双[3,5-二叔丁基-4-甲氧基苯基]-1,1'-联萘酚 | ≥98%,99%e.e. | 1353682-93-5 | 100mg |
3262.00
3262.00 |
咨询 |
|
| 麦克林 | N857171-100mg | (S)-N,N',N,N'-四甲基联萘胺 | 98%,ee99% | 135759-57-8 | 100mg |
3500.00
3500.00 |
咨询 |
|
| 麦克林 | R854263-100mg | (11aR)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1372719-95-3 | 100mg |
7391.00
7391.00 |
咨询 |
|
| 麦克林 | R854105-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-di-9-phenanthrenyl-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1372719-96-4 | 100mg |
5215.00
5215.00 |
咨询 |
|
| 麦克林 | R854111-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-bis(triphenylsilyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1372719-97-5 | 100mg |
3712.00
3712.00 |
咨询 |
|
| 麦克林 | S854214-100mg | (S)-3,3'-双(4-甲氧基苯基)-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1374030-19-9 | 100mg |
3645.00
3645.00 |
咨询 |
|
| 麦克林 | S854227-100mg | (11bS)-2,6-Bis(3,5-dichlorophenyl)-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 1374030-20-2 | 100mg |
3116.00
3116.00 |
咨询 |
|
| 麦克林 | R853912-100mg | (11bR)-8,9,10,11,12,13,14,15-Octahydro-N,N-bis[(1R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine | ≥95%,≥99%e.e. | 1389329-66-1 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | S854072-100mg | (S)-3,3'-双(3,5-二甲基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚 | ≥98%,99%e.e. | 1402852-05-4 | 100mg |
1982.00
1982.00 |
咨询 |
|
| 麦克林 | S854273-100mg | (11aS)-3,7-Bis(4-nitrophenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin | ≥98%,99%e.e. | 1412439-84-9 | 100mg |
5411.00
5411.00 |
咨询 |
|
| 麦克林 | B854121-100mg | (4R,4'R)-2,2'-异丙亚基双(4-苄基-2-噁唑啉) | ≥95%,99%e.e. | 141362-77-8 | 100mg |
1518.00
1518.00 |
咨询 |
|
| 麦克林 | S854312-100mg | (S)-2-[Bis[3,5-bis(trifluoromethyl)phenyl][[trisisopropylsilyl]oxy]methyl]pyrrolidine | ≥98%,99%e.e. | 1415760-15-4 | 100mg |
1912.00
1912.00 |
咨询 |
|
| 麦克林 | S854178-100mg | (2S)-2-[[[[(1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 | ≥98%,99%e.e. | 1421052-39-2 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | S854179-100mg | (2S)-2-[[[[(1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 | ≥98%,99%e.e. | 1421697-46-2 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | R854115-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-bis[4-(trifluoromethyl)phenyl]-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1435948-34-7 | 100mg |
4522.00
4522.00 |
咨询 |
|
| 麦克林 | R854117-100mg | (R)-2,2',3,3'-Tetrahydro-6,6'-bis(2,4,6-trimethylphenyl)-1,1'-spirobi[1H-indene]-7,7'-diol | ≥98%,99%e.e. | 1435948-37-0 | 100mg |
5400.00
5400.00 |
咨询 |
|
| 麦克林 | X833017-100mg | 黄嘌呤核苷 | ≥98.0%(HPLC) | 146-80-5 | 100mg |
146.00
146.00 |
咨询 |
|
| 麦克林 | S853897-100mg | (4S)-2-[2-(Diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole | ≥95%,≥99%e.e. | 148461-15-8 | 100mg |
3543.00
3543.00 |
咨询 |
|
| 麦克林 | S854180-100mg | (2S)-2-[[[[3,5-双(三氟甲基)苯基]氨基]硫代甲基]氨基]-3,3-二甲基-N-(苯基甲基)丁酰胺 | ≥98%,99%e.e. | 1490388-03-8 | 100mg |
2587.00
2587.00 |
咨询 |
|
| 麦克林 | S854218-100mg | (S)-3,3'-双(3,5-二苯基苯基)-1,1'-联萘酚膦酸酯 | ≥98%,99%e.e. | 1496637-05-8 | 100mg |
4569.00
4569.00 |
咨询 |
|
| 麦克林 | S854085-100mg | (S)-5,5',6,6',7,7',8,8'-八氢-3,3'-双(3,5-二苯基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1496637-08-1 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | S854246-100mg | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 1496637-09-2 | 100mg |
5697.00
5697.00 |
咨询 |
|
| 麦克林 | S854058-100mg | (S)-3,3'-Bis(3,5-二苯基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1496637-10-5 | 100mg |
2587.00
2587.00 |
咨询 |
|
| 麦克林 | R854057-100mg | (R)-3,3'-Bis(3,5-二苯基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1539285-81-8 | 100mg |
2587.00
2587.00 |
咨询 |
|
| 麦克林 | R854084-100mg | (R)-5,5',6,6',7,7',8,8'-八氢-3,3'-双(3,5-二苯基苯基)-1,1'-联萘酚 | ≥98%,99%e.e. | 1539286-01-5 | 100mg |
3037.00
3037.00 |
咨询 |
|
| 麦克林 | R829433-100mg | (R)-(-)-1[(S)-2-(二苯基膦)二茂铁]乙基二环己基膦 | 97% | 155806-35-2 | 100mg |
888.00
888.00 |
咨询 |
|
| 麦克林 | R854186-100mg | (2R)-2-Amino-3-methyl-N-2-pyridinylbutanamide | ≥98%,99%e.e. | 1568043-19-5 | 100mg |
1350.00
1350.00 |
咨询 |
|
| 麦克林 | R854245-100mg | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 1569807-15-3 | 100mg |
5697.00
5697.00 |
咨询 |
|